Zinc Completed Phase 2 Trials for Malignant Lymphomas Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00490009Phase II Study of Bexxar in Relapsed/Refractory Diffuse Large Cell Lymphoma